Esperion Therapeutics, Inc. earnings per share and revenue

ESPR earnings per share for the last quarter are -0.33 USD whereas the estimation was -0.17 USD which accounts for -91.70% surprise. Company revenue for the same period amounts to 73.83 M USD despite the estimated figure of 47.49 M USD. Estimated earnings per share for the next quarter are -0.18 USD, and revenue is expected to reach 51.31 M USD. Also watch annual changes over time to get a bigger picture of ESPR earnings per share and revenue dynamics.